AAAAAA

   
Results: 1-10 |
Results: 10
Surfactant protein B labelled with [Tc-99m(CO)(3)(H2O)(3)](+) retains biological activity in vitro
Authors: Amann, A Decristoforo, C Ott, I Wenger, M Bader, D Alberto, R Putz, G
Citation: A. Amann et al., Surfactant protein B labelled with [Tc-99m(CO)(3)(H2O)(3)](+) retains biological activity in vitro, NUCL MED BI, 28(3), 2001, pp. 243-250
Methodological considerations influence the clinical value of parathyroid localisation diagnostics
Authors: Gabriel, M Erler, H Bacher-Stier, C Kendler, D Donnemiller, E Decristoforo, C Moncayo, R Gabriel, M
Citation: M. Gabriel et al., Methodological considerations influence the clinical value of parathyroid localisation diagnostics, EUR J NUCL, 28(7), 2001, pp. 942-943
Tc-99m-EDDA/HYNIC-TOC: a new Tc-99-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with In-111-labelled octreotide derivatives
Authors: Decristoforo, C Mather, SJ Cholewinski, W Donnemiller, E Riccabona, G Moncayo, R
Citation: C. Decristoforo et al., Tc-99m-EDDA/HYNIC-TOC: a new Tc-99-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with In-111-labelled octreotide derivatives, EUR J NUCL, 27(9), 2000, pp. 1318-1325
Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide
Authors: Decristoforo, C Cholewinski, W Donnemiller, E Riccabona, G Moncayo, R Mather, SJ
Citation: C. Decristoforo et al., Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide, EUR J NUCL, 27(10), 2000, pp. 1580-1580
Tc-99m-HYNIC-[Tyr(3)]-octreotide for imaging somatostatin-receptor-positive tumors: Preclinical evaluation and comparison with In-111-octreotide
Authors: Decristoforo, C Melendez-Alafort, L Sosabowski, JK Mather, SJ
Citation: C. Decristoforo et al., Tc-99m-HYNIC-[Tyr(3)]-octreotide for imaging somatostatin-receptor-positive tumors: Preclinical evaluation and comparison with In-111-octreotide, J NUCL MED, 41(6), 2000, pp. 1114-1119
Radiochemical purity of routinely prepared Tc-99(m) radiopharmaceuticals: A retrospective study
Authors: Decristoforo, C Siller, R Chen, F Riccabona, G
Citation: C. Decristoforo et al., Radiochemical purity of routinely prepared Tc-99(m) radiopharmaceuticals: A retrospective study, NUCL MED C, 21(4), 2000, pp. 349-354
Preparation, Tc-99m-labeling, and in vitro characterization of hynic and N3S modified RC-160 and [TYR3]octreotide (vol 10, pg 437, 1999)
Authors: Decristoforo, C Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Preparation, Tc-99m-labeling, and in vitro characterization of hynic and N3S modified RC-160 and [TYR3]octreotide (vol 10, pg 437, 1999), BIOCONJ CHE, 10(4), 1999, pp. 701-702
Preparation, Tc-99m-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr(3)]octreotide
Authors: Decristoforo, C Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Preparation, Tc-99m-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr(3)]octreotide, BIOCONJ CHE, 10(3), 1999, pp. 431-438
99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicityand stability on biodistribution
Authors: Decristoforo, C Mather, SJ
Citation: C. Decristoforo et Sj. Mather, 99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicityand stability on biodistribution, NUCL MED BI, 26(4), 1999, pp. 389-396
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence
Authors: Decristoforo, C Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence, EUR J NUCL, 26(8), 1999, pp. 869-876
Risultati: 1-10 |